We’re launching a video series: Partnering on the Edge: The Hard Work of Partnering Well. As part of our deep and long-standing engagement with ASAP, it will be made available to the ASAP community as sponsored content as well as on our YouTube channel and...
Partnering Guide
Upcoming Presentations Highlight the Alliance Leader’s Evolving Mandate
September features both an online presentation and the ASAP Summit London. Our focus is on the alliance leader’s evolving mandate to maximize value capture from their alliances. On September 9, we will be leading an online program incorporating roundtable discussions...
The Execution Edge: The Alliance Professional’s Mandate
Biopharma leaders already understand the industry’s business model has fundamentally shifted. Partnering isn’t an adjunct to internal R&D or a strategic lever pulled selectively. It is the operating model. The work of discovering, developing, and delivering...
When Strategy Misaligns: A Leadership Playbook for Protecting Value in High-Stakes Biopharma Alliances
Strategic misalignment is not a rare disruption in biopharmaceutical alliances—it is an expected outcome of operating in a dynamic, interdependent industry. It is an inevitability, driven by shifting portfolios, leadership turnover, scientific advances, and external...
A Strategic Imperative: The Collaborative Capability of Biopharma Leadership
The biopharma industry’s business model now depends structurally and irreversibly on multi-party execution. Scientific, regulatory, political, and commercial conditions have converged to create unprecedented interdependence. Modalities are more diverse. Clinical...
A Spotlight on Maximizing Alliance Value Realization
Alliances have long been a core strategy of biopharmaceutical companies. From early-stage biotech discovery partnerships to global codevelopment and cocommercialization pacts, these collaborations create value for the partners by accelerating drug development,...
Making the Case for Strategic Alliance Management Operations: Smart Strategy in Lean Times
In today’s biopharma landscape, complexity is the constant. Portfolios are expanding—not just in size, but in diversity. Collaborations span research to commercialization, startups to multinationals, and molecules to digital platforms. Meanwhile, tightening budgets,...
Alliance Leadership in Anxious Times: Strategies for the New Reality
The biopharmaceutical environment is defined by uncertainty and turbulence. Indiscriminate and sudden cancellation of research grants, workforce contractions, shifting regulatory and policy landscapes, and supply chain instability have become the new reality. Add...
Upcoming Events Explore Alliance Leadership Strategies for Driving Value in Challenging Times
Despite the uncertainty and turbulence defining our economic environment, it has never been more important to partner effectively and realize the intended value of alliances. Based on recent experiences with forward-thinking alliance leaders, a number of core...
Reimagining Stakeholder Engagement: Creating Value and Driving Impact
Historically, alliance professionals have faced challenges engaging senior executives effectively. Too often, interactions center on routine updates rather than forward-looking, strategic discussions. At the 2025 ASAP Summit in Denver, Jan Twombly shared techniques to...
As Seen in Strategic Alliance Quarterly: Better Team Collaboration Means Better Alliance Outcomes
Collaboration Is Not a Discrete Skill but a Way of Working—and the Data Shows That Improving Your Teams’ Collaboration Leads to Improved Alliance Results. ...
Improving Alliance Outcomes through Better Team Collaboration at the 22nd Annual Strategic Alliance Management Congress
We are pleased to once again sponsor the 2025 Strategic Alliance Management Congress – and this year it is in Boston on March 25 and 26! Jan will be leading an interactive workshop examining real-world scenarios and sharing frameworks and tools for helping alliance...












